Hinge Health (NYSE:HNGE) Announces Earnings Results

Hinge Health (NYSE:HNGE) posted its quarterly earnings results on Tuesday. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18, Zacks reports. The company had revenue of $154.21 million during the quarter, compared to analyst estimates of $142.44 million. The firm’s quarterly revenue was up 53.3% on a year-over-year basis. Hinge Health updated its FY 2025 guidance to EPS and its Q4 2025 guidance to EPS.

Hinge Health Stock Performance

Shares of NYSE HNGE traded down $1.36 during midday trading on Thursday, hitting $44.03. 1,884,043 shares of the company’s stock were exchanged, compared to its average volume of 1,037,442. The firm has a fifty day simple moving average of $52.93. Hinge Health has a twelve month low of $33.42 and a twelve month high of $62.18.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Ameriprise Financial Inc. purchased a new position in Hinge Health during the 2nd quarter worth approximately $27,040,000. Squarepoint Ops LLC purchased a new position in Hinge Health during the 2nd quarter worth approximately $19,706,000. Bank of America Corp DE purchased a new position in Hinge Health during the 2nd quarter worth approximately $11,680,000. Balyasny Asset Management L.P. purchased a new position in Hinge Health during the 2nd quarter worth approximately $11,124,000. Finally, Gilder Gagnon Howe & Co. LLC purchased a new position in Hinge Health during the 2nd quarter worth approximately $9,618,000.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Barclays increased their price target on Hinge Health from $62.00 to $65.00 and gave the company an “overweight” rating in a research report on Wednesday. JMP Securities increased their price target on Hinge Health from $58.00 to $65.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 6th. Canaccord Genuity Group increased their price target on Hinge Health from $61.00 to $65.00 and gave the company a “buy” rating in a research report on Wednesday. Evercore ISI raised their target price on Hinge Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. Finally, Baird R W raised Hinge Health to a “hold” rating in a research report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $59.93.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.